BOCA RATON, Fla., April 28, 2016 (GLOBE NEWSWIRE) -- RxStrategies, Inc. is pleased to announce the appointment of Todd Hudnall to the new position of Sales Manager - Midwest Region. He joins the RxStrategies sales team and has responsibility for sales and delivery of customized 340B pharmacy administration and split billing solutions to providers located in the Midwest Region.
"I am very pleased to welcome Todd to the RxStrategies team,” said Fenton Markevich, Chief Executive Officer for RxStrategies. “We look forward to incorporating Todd’s market and product expertise and knowledge for the benefit of our existing and future clients. We believe that Todd will be a strong addition and will complement our current market facing sales and account management teams.”
Todd joins RxStrategies with strong 340B knowledge combined with an extensive pharmacy industry, 340B wholesaler and government background. He has a particularly strong presence in the Midwest in market facing roles to the pharmacy administration and 340B markets. Todd is a graduate of Marshall University.
"RxStrategies has a strong reputation in the marketplace with both a unique and transparent contract pharmacy processing solution, and a proprietary split billing solution for this complex market," said Hudnall. "I am excited to join a growing industry leader and bring value to clients and prospects by using a consultative approach. I look forward to continuing that tradition by providing 340B guidance and insight to our current and future clients."
About RxStrategies, Inc.
Established in 2003 and headquartered in Boca Raton, Florida, RxStrategies, Inc. provides accountability, transparency and value-based solutions for the Federal 340B Drug Pricing Programs. As a full-service 340B Drug Pricing Program services organization, RxStrategies provides a diverse range of services to all “Qualified Entities” and the in-house and/or contract pharmacies, including 340B administration, split billing, orphan drug, and audit services. RxStrategies’ “real-time” comprehensive solutions are designed to meet the challenges of regulatory compliance, patient eligibility, pharmacy replenishment, program tracking and reporting of the Federal 340B Drug Pricing Program. To learn more, please visit www.340Bplus.com.
Media Contact: Cheryl Musial, Media Relations, Mopdog, Inc. firstname.lastname@example.org 678-737-7325